One of the successor companies of the old maker of Marlboro cigarettes has gone big in smokeless as smoking has declined ...

Philip Morris' premium valuations are justified by ZYN's FDA approval, smoke-free growth, and market dominance. See why PM ...

I rate PM shares a "hold" due to optimistic current valuations and potential risks in the smokefree business, despite its ...

White snus pouches were designed to help Swedish women quit cigarettes. They’ve become a staple for American dudes.

It's about time we rewarded people with crippling nicotine addiction! Only those who bought at least 200 tins of Zyn were ...

Philip Morris International Inc. (NYSE: PM) is reportedly exploring the sale of its cigar business for over $1 billion, ...

Philip Morris is considering selling its U.S. cigar business for over $1 billion as it shifts toward smoke-free products. The ...

Philip Morris International (PM) is looking to sell its U.S. cigar business for over $1 billion, Bloomberg reported. This potential sale is ...

The increase in quarterly sales is a continuous development following strong growth from its products ZYN and IQOS. Philip Morris International Inc. (NYSE:PM) projected stronger-than-expected ...

The cigar business was part of Swedish Match AB, which Philip Morris acquired in a $16 billion deal that was completed in 2023. That deal, which added Zyn nicotine pouches to its portfolio ...